These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
    Author: El-Zawahry BM, Zaki NS, Bassiouny DA, Sobhi RM, Zaghloul A, Khorshied MM, Gouda HM.
    Journal: J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286.
    Abstract:
    BACKGROUND: In stable vitiligo, several techniques of autologous transplantation of melanocytes are used. Autologous melanocyte transplantation of non-cultured melanocytes is one of those techniques with variable reported outcomes. OBJECTIVE: The objective of this study was to evaluate the response to autologous melanocyte-keratinocytes suspension transplantation in cases of stable vitiligo. METHODS: A total of 25 cases of vitiligo were treated by autologous melanocyte-keratinocytes suspension transplantation. After 6-17 months, patients' response was evaluated according to the extent of pigmentation (excellent 90-100%, good 50-89%, fair 20-49% and poor response <20%). RESULTS: Of the 25 patients treated, 22 continued the follow-up period. Five (23%) patients showed excellent response, 7 (32%) good, 6 (27%) fair and 4(18%) showed poor response. CONCLUSION: Unlike transplantation of cultured melanocytes, which requires experience in culture technique, autologous melanocyte-keratinocytes suspension transplantation is an easy economic technique, which may be used in resistant areas of stable vitiligo.
    [Abstract] [Full Text] [Related] [New Search]